The history of mast cell and basophil research - Some lessons learnt from the last century

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 9, 2013, Pages 1093-1101

  Blank, U ^a,b   Falcone, F H ^c   Nilsson, G ^d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

allergy; anaphylaxis; basophils; history; mast cells

Indexed keywords

ARACHIDONIC ACID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE; MESSENGER RNA; PATTERN RECOGNITION RECEPTOR; SLOW REACTING SUBSTANCE; STEM CELL FACTOR; THYMIC STROMAL LYMPHOPOIETIN; VASCULOTROPIN;

ADAPTIVE IMMUNITY; ANAPHYLAXIS; ANGIOGENESIS; ANTIBODY TITER; ANTIGEN SPECIFICITY; AUTOIMMUNITY; BASOPHIL; CELL DIFFERENTIATION; CELL GROWTH; CHEMICAL STRUCTURE; CLAVICEPS PURPUREA; CYTOKINE RELEASE; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HYPERSENSITIVITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGENICITY; IMMUNOSTIMULATION; INNATE IMMUNITY; INTESTINE MUSCLE; MAST CELL; MOLECULAR CLONING; NERVE CELL PLASTICITY; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SERUM FACTOR; SIGNAL TRANSDUCTION; TUMOR IMMUNITY;

ALLERGY; ANAPHYLAXIS; BASOPHILS; HISTORY; MAST CELLS;

ANAPHYLAXIS; ANIMALS; BASOPHILS; HISTORY, 20TH CENTURY; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN E; MAST CELLS; PARASITIC DISEASES; RESEARCH;

EID: 84884987749     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12197     Document Type: Review

References (112)

1. von Recklinghausen F,. Über Eiter und Bindegewebskörperchen. Virchows Arch Pathol Anat Physiol Klin Med 1863; 28: 157-197.
2. Ehrlich P,. Beiträge zur Theorie und Praxis der histologischen Färbung. Test (Hrsg.), I. Teil: Die chemische Auffassung der Färbung. II. Teil: Die Anilinfarben in chemischer, technologischer und histologischer Beziehung. Leipzig, 1878. 65 S. Zgl.: Leipzig, Univ., Diss., 1878.
3. Ehrlich P,. Ueber die specifischen Granulationen des Blutes. Archiv fuer Anatomie und Physiologie: Physiologische Abteilung 1879; 571-579.
4. Ehrlich P,. Zur Geschichte der Granula. In: Himmelweit. editor. Farbenanalytische Studien zur Histologie und Klinik des Blutes. Gesamelte Mitteilungen, 1891: 134-137.
5. Portier P, Richet C,. De l'action anaphylactique de certain venins. C R Soc Bio 1902; 54: 170-172.
6. Silverstein AM,. Cellular versus humoral immunology: a century-long dispute. Nat Immunol 2003; 4: 425-428.
7. Arthus M,. Injections répétées de sérum de cheval chez le lapin. C.R. Soc Biol 1903; 55: 817-820.
8. von Pirquet C, Schick B,. Die Serumkrankheit. Leipzig: Deuticke, 1905.
9. Ramirez MA,. Horse asthma following blood transfusion report of case. JAMA 1919; 73: 984-985.
10. Prausnitz C, Küstner H,. Studien über die Ueberempfindlichkei. Zentralbl Bakteriol 1921; 86: 160-169.
11. von Pirquet C,. Allergie. Münch Med Wochenschr 1906; 53: 1457-1458.
12. Richet C,. Effet anaphylactogène dû à une toxine, la congestine, nécessitant une accumulation. Bull Soc Biol 1903; 55: 246-253.
13. Friedberger E,. Theorien über die Anaphylaxie. Z Immun Exp Ther 1909; 2: 208-224.
14. Osler AG, Randall HG, Hill BM, Ovary Z,. Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin. J Exp Med 1959; 110: 311-339.
15. Arthus M,. De l'anaphylaxie à l'immunité. Paris: Masson, 1921.
16. von Pirquet C,. Allergie. Berlin: Springer, 1910.
17. Richet C,. L'Anaphylaxie. Paris: Alcan. 1914.
18. Nicolle M,. Contribution à l'étude du phénomè ne d'Arthus. Ann Inst Pasteur 1907; 21: 128-137.
19. Ishizaka K, Ishizaka T,. Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin. J Allergy 1966; 37: 169-185.
20. Ishizaka K, Ishizaka T,. Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol 1967; 99: 1187-1198.
21. Johansson SG, Bennich H,. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 1967; 13: 381-394.
22. Stanworth DR, Humphrey JH, Bennich H, Johansson SG,. Specific inhibition of the Prausnitz-Kustner reaction by an atypical human myeloma protein. Lancet 1967; 2: 330-332.
23. Johansson SG,. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967; 2: 951-953.
24. Bennich HH, Ishizaka K, Johansson SGO, Rowe DS, Stanworth DR, Terry WD,. Immunoglobulin E, a new class of Immunoglobulin. Bull World Health Organ 1968; 38: 151-152.
25. Schultz WH,. Physiological studies in anaphylaxis. II. Reaction of smooth muscle from guinea pigs rendered tolerant to large doses of serum. J Pharmacol 1910; 2: 221-229.
26. Dale H, Laidlaw PP,. The physiological action of b-iminazolylethylamine. J Physiol 1911; 20: 156-166.
27. Riley JF, West GB,. The presence of histamine in tissue mast cells. J Physiol 1953; 120: 528-537.
28. Lichtenstein LM, Norman PS, Connell JT,. Comparison between skin-sensitizing antibody titers and leukocyte sensitivity measurements as an index of the severity of ragweed hay fever. J Allergy 1967; 40: 160-167.
29. Ishizaka K, Tomioka H, Ishizaka T,. Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol 1970; 105: 1459-1467.
30. Tomioka H, Ishizaka K,. Mechanisms of passive sensitization. II. Presence of receptors for IgE on monkey mast cells. J Immunol 1971; 107: 971-978.
31. Kulczycki A Jr, Isersky C, Metzger H,. The interaction of IgE with rat basophilic leukemia cells. I. Evidence for specific binding of IgE. J Exp Med 1974; 139: 600-616.
32. Blank U, Ra C, Miller L, White K, Metzger H, Kinet JP,. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 1989; 337: 187-189.
33. Miller L, Blank U, Metzger H, Kinet JP,. Expression of high-affinity binding of human immunoglobulin E by transfected cells. Science 1989; 244: 334-337.
34. Marchand F, Mecheri S, Guilloux L, Iannascoli B, Weyer A, Blank U,. Human serum IgE-mediated mast cell degranulation shows poor correlation to allergen-specific IgE content. Allergy 2003; 58: 1037-1043.
35. Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet JP, Jardetzky TS,. Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha. Nature 2000; 406: 259-266.
36. Chang TW,. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000; 18: 157-162.
37. Lundstrom SL, Saluja R, Adner M, Haeggstrom JZ, Nilsson G, Wheelock CE,. Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. J Lipid Res 2012; 54: 116-126.
38. Euler U,. On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol 1936; 88: 213-234.
39. Fedelberg W, Kellaway C,. Liberation of histamine and the formation of lyscithin-like substances by cobra venom. J Physiol 1938; 94: 187-226.
40. Brocklehurst WE,. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 1960; 151: 416-435.
41. Strandberg K, Uvnas B,. Purification and properties of the slow reacting substance formed in the cat paw perfused with compound 48-80. Acta Physiol Scand 1971; 82: 358-374.
42. Piper PJ, Vane JR,. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 1969; 223: 29-35.
43. Orange RP, Murphy RC, Karnovsky ML, Austen KF,. The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol 1973; 110: 760-770.
44. Murphy RC, Hammarstrom S, Samuelsson B,. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A 1979; 76: 4275-4279.
45. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ 2nd,. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982; 129: 1627-1631.
46. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE,. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987; 50: 809-818.
47. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE,. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989; 339: 64-67.
48. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170: 245-257.
49. Seder RA, Paul WE, Dvorak AN, Sharkis SJ, Kagey-sobotka A, Niv Y, et al. Mouse splenic and bone marrow cell populations that express high-affinity Fcepsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci USA 1991; 88: 2835.
50. Gibbs BF, Haas H, Falcone FH, Albrecht C, Vollrath IB, Noll T, et al. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol 1996; 26: 2493-2498.
51. Ochensberger B, Daepp GC, Rihs S, Dahinden CA,. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 1996; 88: 3028-3037.
52. Li H, Sim TC, Alam R,. IL-13 released by and localized in human basophils. J Immunol 1996; 156: 4833-4838.
53. Gordon JR, Galli SJ,. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346: 274-276.
54. Galli SJ, Nakae S, Tsai M,. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-142.
55. Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T,. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011; 29: 45-69.
56. Saarinen JV, Harvima RJ, Naukkarinen A, Horsmanheimo M, Harvima IT,. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin. Allergy 2001; 56: 58-64.
57. Ackermann L, Harvima IT, Pelkonen J, Ritamaki-Salo V, Naukkarinen A, Harvima RJ, et al. Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 1999; 140: 624-633.
58. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-480.
59. Kitamura Y, Shimada M, Hatanaka K, Miyano Y,. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 1977; 268: 442-443.
60. Kitamura Y, Go S,. Decreased production of mast cells in S1/S1d anemic mice. Blood 1979; 53: 492-497.
61. Kitamura Y, Go S, Hatanaka K,. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978; 52: 447-452.
62. Galli SJ, Kitamura Y,. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol 1987; 127: 191-198.
63. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A,. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988; 335: 88-89.
64. Witte ON,. Steel locus defines new multipotent growth factor. Cell 1990; 63: 5-6.
65. Ihle JN, Keller J, Oroszlan S, Henderson LE, Copeland TD, Fitch F, et al. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol 1983; 131: 282-287.
66. Valent P, Schmidt G, Besemer J, Mayer P, Zenke G, Liehl E, et al. Interleukin-3 is a differentiation factor for human basophils. Blood 1989; 73: 1763-1769.
67. Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80: 3009-3021.
68. Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD,. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34 + pluripotent progenitor cells. J Immunol 1992; 148: 772-777.
69. Mitsui H, Furitsu T, Dvorak AM, Irani AM, Schwartz LB, Inagaki N, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A 1993; 90: 735-739.
70. Valent P, Spanblochl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80: 2237-2245.
71. Leary AG, Ogawa M,. Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells. Blood 1984; 64: 78-83.
72. Denburg JA, Telizyn S, Messner H, Lim B, Jamal N, Ackerman SJ, et al. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 1985; 66: 312-318.
73. Zucker-Franklin D,. Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 1980; 56: 534-540.
74. Li L, Li Y, Reddel SW, Cherrian M, Friend DS, Stevens RL, et al. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J Immunol 1998; 161: 5079-5086.
75. Holmgren A, Wilander Z,. Beitrag zur Kenntnis der Chemie und Funktion der Ehrlichschen Mastzelle. Zeitschrift f mikr anat Forsch 1937; 42: 242-278.
76. Enerback L,. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand 1966; 66: 289-302.
77. Enerback L,. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathol Microbiol Scand 1966; 66: 303-312.
78. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB,. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 1986; 83: 4464-4468.
79. Lowman MA, Rees PH, Benyon RC, Church MK,. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 1988; 81: 590-597.
80. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST,. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995; 155: 297-307.
81. Andersson CK, Mori M, Bjermer L, Lofdahl CG, Erjefalt JS,. Novel site-specific mast cell subpopulations in the human lung. Thorax 2009; 64: 297-305.
82. Galli SJ, Grimbaldeston M, Tsai M,. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008; 8: 478-486.
83. Jones TD, Mote JR,. The phases of foreign protein sensitization in human beings. N Engl J Med 1934; 210: 120-123.
84. Trager W,. Acquired immunity to ticks. J Parasitol 1939; 25: 57-81.
85. Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N, et al. Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest 2010; 120: 2867-2875.
86. Stewart DF,. Studies on resistance of sheep to infestation with Haemonchus contortus and Trichostrongylus spp. and on the immunological reactions of sheep exposed to infestation. V. The nature of the "self-cure" phenomenon. Aust J Agric Res 1953; 4: 100-117.
87. Ogilvie BM,. Reagin-like antibodies in animals immune to helminth parasites. Nature 1964; 204: 91-92.
88. Jarrett E, Bazin H,. Elevation of total serum IgE in rats following helminth parasite infection. Nature 1974; 251: 613-614.
89. Miller HR, Jarrett WF,. Immune reactions in mucous membranes. I. Intestinal mast cell response during helminth expulsion in the rat. Immunology 1971; 20: 277-288.
90. Urquhart GM, Mulligan W, Eadie RM, Jennings FW,. Immunological studies on Nippostrongylus brasiliensis infection in the rat: the role of local anaphylaxis. Exp Parasitol 1965; 17: 210-217.
91. Uber CL, Roth RL, Levy DA,. Expulsion of Nippostrongylus brasiliensis by mice deficient in mast cells. Nature 1980; 287: 226-228.
92. Min B,. Basophils: what they 'can do' versus what they 'actually do'. Nat Immunol 2008; 9: 1333-1339.
93. Ohnmacht C, Voehringer D,. Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. J Immunol 2010; 184: 344-350.
94. Medzhitov R,. Approaching the asymptote: 20 years later. Immunity 2009; 30: 766-775.
95. Hook WA, Siraganian RP, Wahl SM,. Complement-induced histamine release from human basophils. I. Generation of activity in human serum. J Immunol 1975; 114: 1185-1190.
96. Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW,. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest 1979; 64: 804-811.
97. Dahinden CA, Kurimoto J, Baggiolini M, Dewald B, Walz A,. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF. Int Arch Allergy Appl Immunol 1989; 90: 113-118.
98. Patella V, Florio G, Petraroli A, Marone G,. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol 2000; 164: 589-595.
99. Schramm G, Falcone FH, Gronow A, Haisch K, Mamat U, Doenhoff MJ, et al. Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. J Biol Chem 2003; 278: 18384-18392.
100. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M,. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23: 749-786.
101. McAlpine SM, Enoksson M, Lunderius-Andersson C, Nilsson G,. The effect of bacterial, viral and fungal infection on mast cell reactivity in the allergic setting. J Innate Immun 2011; 3: 120-130.
102. Abraham SN, St John AL,. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010; 10: 440-452.
103. Beghdadi W, Madjene LC, Benhamou M, Charles N, Gautier G, Launay P, et al. Mast cells as cellular sensors in inflammation and immunity. Front Immunol 2011; 2: 37.
104. Galli S,. New concepts about the mast cell. N Engl J Med 1993; 328: 257-265.
105. Marshall JS,. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4: 787-799.
106. Hepworth MR, Danilowicz-Luebert E, Rausch S, Metz M, Klotz C, Maurer M, et al. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proc Natl Acad Sci U S A 2012; 109: 6644-6649.
107. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-258.
108. Falcone FH, Haas H, Gibbs BF,. The human basophil: a new appreciation of its role in immune responses. Blood 2000; 96: 4028-4038.
109. Schneider E, Thieblemont N, De Moraes ML, Dy M,. Basophils: new players in the cytokine network. Eur Cytokine Netw 2010; 21: 142-153.
110. Bischoff SC,. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7: 93-104.
111. Pejler G, Ronnberg E, Waern I, Wernersson S,. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 2010; 115: 4981-4990.
112. Trivedi NN, Caughey GH,. Mast cell peptidases: chameleons of innate immunity and host defense. Am J Respir Cell Mol Biol 2010; 42: 257-267.